(MedPage Today) -- A first-in-human percutaneous aorto-coronary bypass procedure, dubbed "VECTOR," was used to prevent coronary obstruction following transcatheter aortic valve replacement in a patient ineligible for leaflet modification. (Circulation......
Read more


















